Skip to main content

Institute of Human Virology (IHV) Awarded $24.5M to Fight Botswana’s AIDS Epidemic

June 23, 2015

Robert Gallo, MD

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine has received a five-year $24.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to partner with the Government of Botswana and impact the HIV/AIDS epidemic in Botswana, and to demonstrate that comprehensive HIV/AIDS treatment programs can stop the epidemic. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush, and continued by President Barack Obama, to combat major infectious diseases around the world, including HIV. The announcement was made on the heels of two recent IHV milestones including surpassing more than 1 million in patients in overseas care and treatment and a $50 million grant to combat HIV/AIDS in Zambia.

“This new partnership between our Institute and the Government of Botswana is a credit to the work IHV’s Clinical Division carries out internationally under the leadership of my colleague and fellow IHV co-founder, Dr. Robert Redfield,” said Robert Gallo, MD, Homer & Martha Gudelsky Distinguished Professor of Medicine and Director, Institute of Human Virology, University of Maryland School of Medicine. Dr. Gallo is most widely known for his co-discovery of HIV as the cause of AIDS and development of the HIV blood test. He continued, “We look forward to partnering with Botswana, as we have done in nine other nations through PEPFAR funding, to continue putting the first real dent in the global AIDS pandemic.”

The five-year program known as the Botswana-University of Maryland School of Medicine Health Initiative (BUMMHI) will achieve the following objectives: 1) ensure universal access to comprehensive HIV/AIDS services, measured by at least 90% of HIV infected individuals receiving treatment and maintenance of care, and achieving viral suppression; 2) improve the quality of HIV services through strengthening community to facility care; 3) implement the Prevention of Mother to Child Transmission initiative to achieve PEPFAR’s goal of an HIV/AIDS free generation; and, 4) develop and institutionalize a system for ongoing training of healthcare workers to strengthen and sustain Botswana’s successful HIV/AIDS response.

Robert Redfield, Jr. MD, Professor of Medicine and Division Head, Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, is the Principal Investigator of this new five year grant. He said, “If any country can reach HIV epidemic control goals, it is Botswana. The country’s leadership is heavily invested in improving the health of its citizens and was one of the first countries to provide HIV antiretroviral treatment for its citizens, even before PEPFAR and Global Fund initiatives helped increase treatment in several other countries.”

Of note, Botswana currently funds more than 95% of its HIV treatment program, signifying its commitment for operationalizing a sustained and effective response. The Institute will work with Botswana’s Ministry of Health staff and local healthcare and management professionals to strategically place multi-disciplinary expert teams across the country and to implement key interventions and plans. The IHV, as the prime grant recipient, will collaborate with the U.S. non-profit Education Development Center (EDC) to implement education programs to ensure long-term learning outcomes through innovative teaching methods.

“We hope this new collaboration will lead to Botswana becoming the first country to reach HIV epidemic control status,” said Deus Bazira Mubangizi, DrPH, MBA, MPH, Assistant Professor of Medicine and Director for Global Health in the Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, and co-principal investigator for this grant. “As the main partner to the Government of Botswana in the field of HIV/AIDS, the Institute of Human Virology/University of Maryland has the opportunity to showcase a successful and sustainable model for HIV epidemic control, achieved through cooperation between an American academic institution and a foreign government.”

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit www.ihv.org and follow us on Twitter @IHVmaryland.

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Wednesday, March 06, 2019

    UMSOM Researcher Elected as Fellow to American Academy of Microbiology

    Richard Y. Zhao, Ph.D., Professor of Pathology and Associate Member of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM), has been elected as a Fellow to the American Academy of Microbiology (AAM). AAM is an honorific leadership group within the American Society for Microbiology (ASM).


    Tuesday, December 04, 2018

    Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.


    Wednesday, September 19, 2018

    Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.


    Wednesday, March 21, 2018

    Dr. Robert Redfield, Co-Founder of the Institute of Human Virology at the University of Maryland School of Medicine, to Become CDC Director

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) congratulates its co-founder and associate director, Robert R. Redfield, MD, on his appointment to be the next director of the U.S. Centers for Disease Control and Prevention (CDC).


    Tuesday, March 20, 2018

    UMSOM Cancer Expert at Institute of Human Virology Named Fellow of American Society of Clinical Oncology

    Clement A. Adebamowo, BM, ChB, ScD, FWACS, FACS, Associate Director of Population Science at the Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine (UMSOM), and Professor of Epidemiology and Public Health, Institute of Human Virology, has been named a 2018 Fellow of the American Society of Clinical Oncology (ASCO).


    Wednesday, November 29, 2017

    To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.


    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.


    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.


    Wednesday, April 13, 2016

    IHV Releases Data Supporting Community-Based Treatment Providers in Fight Against Hepatitis C

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine released data today at The International Liver Congress 2016 in Barcelona, Spain demonstrating that treatment for hepatitis C virus (HCV) can be provided safely and effectively within a community-based and non-specialist setting.


    Thursday, March 10, 2016

    UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.


    Tuesday, September 29, 2015

    Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.


    Thursday, April 02, 2015

    IHV Awarded $50 Million to Combat HIV Crisis in Zambia

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine received a $50 million five year grant from the President’s Emergency Plan for AIDS Relief (PEPFAR) to support the program, “Stop Mother and Child HIV Transmission” in Zambia. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush and continued by President Barack Obama. The announcement was made on the heels of IHV reaching the 1 million mark in care for HIV patients overseas.